• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 3. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 4. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 5. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608

• Solvents and Organic Chemicals Organic Compounds Organic 1,3-dipolar compounds Allyl-type 1,3-dipolar organic compounds C-nitro compounds
• Solvents and Organic Chemicals Organic Compounds Organic 1,3-dipolar compounds Allyl-type 1,3-dipolar organic compounds Organic nitro compounds C-nitro compounds

Chemical Profile of 4-nitro-1H-pyridin-2-one (CAS No. 4487-51-8)

4-nitro-1H-pyridin-2-one, identified by its Chemical Abstracts Service (CAS) number 4487-51-8, is a significant heterocyclic compound that has garnered considerable attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the nitropyridine class, a subset of pyridine derivatives characterized by the presence of a nitro group at a specific position on the pyridine ring. The structural and electronic properties imparted by the nitro group make 4-nitro-1H-pyridin-2-one a versatile scaffold for synthesizing various bioactive molecules.

The molecular structure of 4-nitro-1H-pyridin-2-one consists of a six-membered aromatic ring containing nitrogen, with a nitro functional group (-NO?) attached to the 4-position and a carbonyl group (C=O) at the 2-position. This arrangement creates a system with distinct electronic characteristics, including significant resonance stabilization and reactivity patterns. The nitro group, being electron-withdrawing, influences the reactivity of the ring at positions 3 and 5, making it susceptible to nucleophilic substitution reactions under appropriate conditions.

In recent years, 4-nitro-1H-pyridin-2-one has been explored as a key intermediate in the synthesis of pharmacologically relevant compounds. Its ability to undergo reduction to form amino-substituted pyridines or further functionalization via nucleophilic aromatic substitution has made it valuable in constructing more complex molecular architectures. These transformations are particularly useful in drug discovery programs aimed at developing novel therapeutic agents.

One of the most compelling aspects of 4-nitro-1H-pyridin-2-one is its role in the development of small-molecule inhibitors for various biological targets. For instance, derivatives of this compound have been investigated as potential kinase inhibitors, which are critical in treating cancers and inflammatory diseases. The nitro group can be strategically positioned to modulate binding interactions with protein targets, enhancing selectivity and potency. Additionally, the presence of both carbonyl and nitro functionalities allows for further derivatization into amides, esters, or other pharmacophores that may improve solubility or metabolic stability.

Recent advancements in synthetic methodologies have expanded the utility of 4-nitro-1H-pyridin-2-one in medicinal chemistry. Transition-metal-catalyzed cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig couplings, have enabled the introduction of aryl or heteroaryl groups at positions 3 or 5 of the pyridine ring. These modifications have led to the discovery of novel compounds with enhanced pharmacological profiles. Furthermore, computational studies have been employed to optimize synthetic routes and predict the biological activity of derived compounds, streamlining the drug discovery process.

The pharmacological exploration of 4-nitro-1H-pyridin-2-one derivatives has revealed several promising candidates for therapeutic intervention. For example, studies have demonstrated that certain analogs exhibit inhibitory effects on enzymes involved in metabolic pathways relevant to diabetes and obesity. The ability to fine-tune the electronic properties of the pyridine ring through functionalization allows for selective targeting of specific disease pathways without affecting others. This level of precision is crucial for developing drugs with minimal side effects.

Another area where 4-nitro-1H-pyridin-2-one has shown promise is in antiviral research. The structural motif is compatible with modifications that can mimic natural substrates or inhibit key viral enzymes. By leveraging its reactivity and versatility, chemists have synthesized compounds capable of disrupting viral replication cycles. These efforts are particularly relevant in light of emerging infectious diseases where rapid development of antiviral agents is essential.

The synthesis and handling of 4-nitro-1H-pyridin-2-one require careful consideration due to its reactivity and potential hazards associated with organic intermediates. Standard laboratory protocols must be followed to ensure safety and reproducibility. While not classified as a hazardous material under typical conditions, proper ventilation and personal protective equipment (PPE) are recommended during its use. Advances in green chemistry have also prompted investigations into more sustainable synthetic routes for this compound, reducing waste and minimizing environmental impact.

In conclusion, 4-nitro-1H-pyridin-2-one (CAS No. 4487-51-8) represents a valuable building block in pharmaceutical chemistry with diverse applications across multiple therapeutic areas. Its unique structural features enable extensive functionalization, leading to novel bioactive molecules with potential clinical significance. As research continues to uncover new synthetic strategies and pharmacological applications, this compound will undoubtedly remain a cornerstone in medicinal chemistry innovation.

• 18614-54-5(2-Methoxy-4-nitropyridine)
• 1187732-70-2(2-Ethoxy-4-nitropyridine)
• 1229731-53-6(Pyridine, 2,6-dimethoxy-4-nitro-)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)